Analytical Methods

An orthogonal approach to lipid nanoparticle analysis is recommended to optimize drug development success.

Using a minimum valuable product and process approach would make it is possible to discipline and structure the development of biopharmaceuticals in the fastest way possible.

Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.

It is important to understand regulatory requirements and study challenges to develop and validate the appropriate methods for a bioanalytical study program at the clinical stage.

Preclinical testing is better able to evaluate complex drug candidates thanks to innovations in animal model approaches.

The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.

By understanding potential material change, the impact on patient safety can be understood and mitigated.

Bio-Rad’s SEQuoia Express Stranded RNA Library Prep Kit is designed to construct efficient RNA sequencing workflows.

One get obtain a clearer assessment of gene-editing outcomes through more exacting analytical tools.

One can use modeling methods to generate data and shorten development timelines in preclinical studies.

Applying modeling methods in preclinical studies can be a powerful tool for generating data and shortening development timelines.

Effective cleaning and disinfection along with contamination controls are imperative when operating and utilizing a cleanroom.

Bio-Rad has launched a range of antibodies specifically for daratumumab that inhibit the binding of the drug to the target antigen, CD38, which allows for highly specific bioanalysis and drug monitoring.

Scientists can work to overcome the challenges associated with protein characterization through empowering technologies.

The integration of modern software tools can make the acquisition and analysis of MS data more efficient, accurate, and compliant.

The COVID-19 pandemic generated partnerships among organizations with the goal of changing the way in which assay development and tech transfer of these assays are conducted moving forward.

The acquisition of Protein Metrics expands Insightful Science’s R&D solutions to include proteomics.

Modeling techniques can improve process control and monitoring in biopharmaceutical production.

Multispecific analysis is complex but can be achieved using appropriate strategies.

Genezen has opened its new process development and analytical lab for viral vector production.

Bionique Testing Laboratories has been acquired by Asahi Kasei Medical and will join the company’s biosafety testing services unit.

Fully automated enzyme analysis can ease a persistent bottleneck in biocatalyst development for bio/pharmaceutical applications.

The companies will focus on the rapid development of polymerase chain reaction assays for emerging pathogens and potential health threats, including biological threats.

Timing is everything, and it might be ideal for acceleration of real-time monitoring solutions.

Defining expectations, such as GMPs, is paramount for sourcing the right biopharmaceutical raw materials.